Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus

PHASE3CompletedINTERVENTIONAL

Enrollment

862

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions

Staphylococcal Skin Infection

Interventions

DRUG

Telavancin

Telavancin 10 mg/kg/day, IV for up to 14 days.

DRUG

Vancomycin

Vancomycin 1 Gm IV q 12 hrs for up to 14 days.

Trial Locations (1)

Paradise Valley Hospital, 2400 E. 4th Street, National City